HRT Financial’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

HRT Financial’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-57,975	Closed	-$866K	–	3620
2022 Q4	$866K	Buy	+57,975	New	+$803K	0.01%	1052
2021 Q3	–	Sell	-41,428	Closed	-$273K	–	4103
2021 Q2	$273K	Buy	+41,428	New	+$286K	﹤0.01%	2206
2018 Q3	–	Sell	-2,048	Closed	-$46K	–	535
2018 Q2	$46K	Buy	+2,048	New	+$48.6K	0.02%	243

HRT Financial's AVEO Position: Q1 2023 in Review

HRT Financial sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 57,975 shares — an estimated $866K sold.

HRT Financial first reported a position in AVEO in Q2 2018 and held it in 3 quarters. The position peaked at $866K in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

HRT Financial reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
HRT Financial sold 57,975 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $866K.
HRT Financial first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2018 and held it in 3 quarters.
HRT Financial's AVEO Pharmaceuticals, Inc. position peaked at $866K in Q4 2022.
0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on HRT Financial's 13F filing for Q1 2023, filed 12 May 2023.